Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

778 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis.
Staropoli N, Ciliberto D, Luciano F, Napoli C, Costa M, Rossini G, Arbitrio M, Labanca C, Riillo C, Del Giudice T, Crispino A, Salvino A, Galvano A, Russo A, Tassone P, Tagliaferri P. Staropoli N, et al. Among authors: napoli c. Crit Rev Oncol Hematol. 2024 Jan;193:104229. doi: 10.1016/j.critrevonc.2023.104229. Epub 2023 Dec 7. Crit Rev Oncol Hematol. 2024. PMID: 38065404 Free article. Review.
Smartphones' impact on nursing performances: a cross-sectional multicenter study.
Di Simone E, Dionisi S, Giannetta N, Panattoni N, De Leo A, Di Mario S, Surace A, Urban J, Liquori G, Napoli C, Montesano M, Di Muzio M, Orsi GB. Di Simone E, et al. Among authors: napoli c. Ann Ig. 2024 Apr 3. doi: 10.7416/ai.2024.2626. Online ahead of print. Ann Ig. 2024. PMID: 38567704 Free article.
Epigenetic challenges on the horizon of chimeric antigen receptor-T.
Benincasa G, Strozziero MG, Di Pastena MA, Criscuolo C, Cetani G, Trama U, Napoli C. Benincasa G, et al. Among authors: napoli c. Cytotherapy. 2024 May;26(5):411-412. doi: 10.1016/j.jcyt.2024.02.016. Epub 2024 Mar 2. Cytotherapy. 2024. PMID: 38466261 No abstract available.
Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy.
Costa D, Picascia A, Grimaldi V, Amarelli C, Petraio A, Levi A, Di Donato M, Pirozzi AVA, Fiorito C, Moccia G, Gallo A, Strozziero M, Marra C, De Feo M, Cacciatore F, Maiello C, Napoli C. Costa D, et al. Among authors: napoli c. Transpl Immunol. 2024 Apr;83:102011. doi: 10.1016/j.trim.2024.102011. Epub 2024 Feb 23. Transpl Immunol. 2024. PMID: 38403197 Free article.
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.
Germani S, Van Ho AT, Cherubini A, Varone E, Chernorudskiy A, Renna GM, Fumagalli S, Gobbi M, Lucchetti J, Bolis M, Guarrera L, Craparotta I, Rastelli G, Piccoli G, de Napoli C, Nogara L, Poggio E, Brini M, Cattaneo A, Bachi A, Simmen T, Calì T, Quijano-Roy S, Boncompagni S, Blaauw B, Ferreiro A, Zito E. Germani S, et al. Among authors: de napoli c. Cell Rep Med. 2024 Mar 19;5(3):101439. doi: 10.1016/j.xcrm.2024.101439. Epub 2024 Feb 22. Cell Rep Med. 2024. PMID: 38402623 Free PMC article.
778 results